The Magazine for Sleep Professionals
Friday, November 13, 2026
Pulmonx announced that their Zephyr® Endobronchial Valve System is included in a new national coverage policy from Aetna®. With this coverage decision, Aetna’s members will have access to lung volume reduction with the Zephyr Valves, the only FDA approved minimally invasive device for the treatment of patients with emphysema. Zephyr Valves are […]
Royal Philips has launched a global initiative to celebrate everyday wins by patients, providers and caretakers regarding the management of chronic obstructive pulmonary disease (COPD). Launching on World COPD Day on November 21, this awareness and celebratory campaign aims to help inspire COPD patients and their caregivers around ways to improve their overall […]
A new version of Primatene Mist will soon return to the shelves of U.S. stores. The FDA approved the over-the-counter aerosol inhaler late Wednesday. It’s indicated for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up. The original Primatene Mist disappeared seven years ago when the […]
Voorhees Pediatric Facility, a pediatric special care nursing facility located in Voorhees, New Jersey, has had four patients with chronic lung disease contract a mild form of adenovirus. The adenovirus strain at Voorhees Pediatric Facility is not the same virus strain that was identified in the North New Jersey area […]
Diary of a Modern Consumptive by former TB patient, Paul Thorn, tells a remarkable story of survival. In 1995 Paul was infected in an outbreak that occurred at a West London hospital with a multidrug-resistant strain of tuberculosis. He spent three months in negative pressure isolation and was not expected […]
New research from Propeller Health, a digital therapeutics company, suggests that clinical guidelines for assessing asthma control may need to be updated to reflect objective patient information obtained from digital medicines. Propeller’s digital medicine platform helps patients manage diseases like asthma and COPD by delivering concrete insights on symptoms, triggers, […]
Propeller Health’s digital medicines allow Anthem Blue Cross and Blue Shield consumers to better manage COPD symptoms Anthem Blue Cross and Blue Shield in Ohio announced the rollout of an innovative new program, with Propeller Health’s collaboration, to help improve health outcomes for Ohio consumers enrolled in Anthem’s Medicare Advantage […]
Electromed, Inc. announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C. The study’s findings reveal that early use of high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduced severe exacerbations and hospitalizations among non-cystic […]
More than 4 in 10 women with asthma may go on to develop chronic obstructive pulmonary disease (COPD), according to a study conducted in Ontario, Canada, and published online in the Annals of the American Thoracic Society. In “Asthma and COPD Overlap in Women: Incidence and Risk Factors,” Teresa To, […]
Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial published online in the Annals of the American Thoracic Society. In “Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise […]
